欢迎访问新加坡聚知刊出版有限公司官方网站
info@juzhikan.asia
颅内动脉粥样硬化性狭窄管壁成像相关标志物与卒中关系的研究进展
  • ISSN:3029-2816(Online)3029-2808(Print)
  • DOI:10.69979/3029-2808.26.07.070
  • 出版频率:月刊
  • 语言:中文
  • 收录数据库:ISSN:https://portal.issn.org/ ; 中国知网:https://scholar.cnki.net/journal/search ; RCCSE权威核心学术期刊:http://qk.nseac.com

颅内动脉粥样硬化性狭窄管壁成像相关标志物与卒中关系的研究进展
梁美霞1(通讯作者) 于莹2

1镜湖医院,中国澳门,999078;

2弘爱医院,中国厦门,361000;

摘要:颅内动脉粥样硬化性狭窄是缺血性卒中及短暂性脑缺血发作的核心病因之一,尤其在亚洲人群中占据主导地位。传统影像学评估方法,包括CT血管成像与DSA,虽可精准评估管腔狭窄程度及侧支代偿状态,却无法直接显示血管壁本身的病理解剖学改变。近年来,以高分辨率MR血管壁成像为代表的管壁成像技术,实现了从“管腔中心”向“管壁病理”的范式跃迁,使得识别颅内动脉易损斑块的形态学与组织学特征成为可能。该文综述了颅内动脉粥样硬化性狭窄患者中血管壁影像学生物标志物与卒中发生、进展及复发关系的研究进展,以期为缺血性卒中的早期预防提供参考。

关键词:颅内动脉硬化;血管重构;斑块;颅内狭窄;综述

参考文献

[1] 解正绮, 宋晓微。ICAS所致急性缺血性卒中的斑块特征与发病机制关系研究。2025,20(9):1104-1112,DOI:10.3969/j.issn.1673-5765.2025;09.005.

[2] 张金磊,苑杨,颅内动脉粥样硬化性狭窄临床分型、危险因素及发病机制的研究进展[J]。实用心脑肺血管病杂志,2025;33(05):129-132.

[3] Yang P, Wan S, Wang J, et al. Hemodynamic assessment for intracranial atherosclerosis from angiographic images: a clinical validation study. J Neurointerv Surg. 2024;16(2):204-208.

[4] Jiayan L, Lijun W, et al. Hemodynamic evaluation of symptomatic and asymptomatic intracranial atherosclerotic stenosis using cerebral angiographic images: an exploratory study. J Neurointerv Surg. 2025;0:1-5.

[5] Lv Y, Ma X, Zhao W, et al. Association of plaque characteristics with long-term stroke recurrence in patients with intracranial atherosclerotic disease: a 3D high-resolution MRI-based cohort study. Eur Radiol. 2024 May;34(5):3022-3031.

[6] Li J, Liu L, Zhang R, et al. Associations of NETs with inflammatory risk and clinical predictive value in large artery atherosclerosis stroke: a prospective cohort study. Front Immunol. 2024 Dec 16;15:1488317.

[7] Zeng W, Zhou F, Zhao H, et al. Evaluation of intensive statins and proprotein convertase subtilisin/kexin type 9 inhibitors on intracranial artery plaque stability: a prospective single-arm study. J Am Heart Assoc. 2025;14(2):e035651.

[8] Yang K, et al. Vessel wall MRI monitoring of intracranial atherosclerotic plaque changes after lipid-lowering therapy: four case reports. Front Neurol. 2025;16:1456782.

[9] Mo J, Chen Z, Wang M, et al. Lipoprotein-associated phospholipase A2 activity levels is associated with artery to artery embolism in symptomatic intracranial atherosclerotic disease. J Stroke Cerebrovasc Dis. 2024 Nov;33(11):108012.

[10] Gu SY, Zhang LN, Chen J, et al. Associations of plaque morphology and location with intraplaque neovascularization in the carotid artery by contrast-enhanced ultrasound imaging[J]. Front Neurol,2023;14:1097070.

[11] Pranjal R,Vincent EYCh,Andrew JF.et al. Vessel wall imaging at 7T: state of the art. AJNR Am J Neuroradiol. 2025;46(5):891-900.

[12] Zedde M, Del Sette M, Quatrale R, Causin F, Pascarella R. Intracranial vessel wall lesions on MRI: anatomical and pathological issues. Neurol Sci. 2025;46(10):4851-4873.

[13] Wang Y, Fan Z, Song JW, Sui B, Peng R, Balu N, et al. Expert consensus on intracranial vessel wall MRI in cerebrovascular disease: Society for Magnetic Resonance Angiography recommendations. Eur Radiol. 2026;36(4):2105-2122.